See also this year's filing and all EDGAR filings for this company.
PDF Report 0001109196_2016_Mabvax_Therapeutics_Holdings_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001109196, Mabvax Therapeutics Holdings INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 5,308,984 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 6,826,003 |
| 2 | PropertyPlantAndEquipmentNet | 135,486 |
| 3 | remainder_Assets | 126,654 |
| 4 | LiabilitiesCurrent | 4,958,363 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,795,163 |
| 9 | ResearchAndDevelopmentExpense | 9,596,768 |
| 10 | remainder_Expenses | -19,807 |
| 11 | remainder_Revenues | 1,267,036 |
| 12 | remainder_NetIncome | -227 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 12,397,127 |
| 1 | Liabilities | 4,958,363 |
| 2 | Expenses | 19,372,124 |
| 3 | Revenues | 1,267,036 |
| 4 | StockholdersEquity | 7,438,764 |
| 5 | NetIncome | -18,105,315 |
| 6 | ComprehensiveNetIncome | -18,105,315 |
| 7 | BaseVar | 18,997,438 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.218 |
| 9 | EconomicCapitalRatio | 1.41 |
Edgar->Model Mapping
Feature Distribution
